Vasoactive intestinal peptide and bipolar affective illness. Evidence for an effect of lithium.
暂无分享,去创建一个
[1] J. Nurnberger,et al. Muscarinic cholinergic receptors on skin fibroblasts in familial affective disorder. , 1984, The New England journal of medicine.
[2] M. G. Kane,et al. Production of secretory diarrhea by intravenous infusion of vasoactive intestinal polypeptide. , 1983, The New England journal of medicine.
[3] E. Gershon,et al. A twin study of cholinergic REM induction. , 1983, Biological psychiatry.
[4] J. M. George,et al. Specific binding sites for vasoactive intestinal polypeptide on nonadherent peripheral blood lymphocytes. , 1983, Journal of immunology.
[5] H. Kaji,et al. Release of vasoactive intestinal polypeptide into the cerebrospinal fluid of the fourth ventricle of the rat: Involvement of cholinergic mechanism , 1983, Brain Research.
[6] T. Bártfai,et al. Vasoactive intestinal polypeptide enhances muscarinic ligand binding in cat submandibular salivary gland , 1982, Nature.
[7] J. Nurnberger,et al. Faster cholinergic REM sleep induction in euthymic patients with primary affective illness. , 1980, Science.
[8] T. Hökfelt,et al. Vasoactive intestinal polypeptide in cholinergic neurons of exocrine glands: functional significance of coexisting transmitters for vasodilation and secretion. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[9] C. Mazure,et al. Blindness and reliability in lifetime psychiatric diagnosis. , 1979, Archives of general psychiatry.
[10] A. M. Ebeid,et al. Release of vasoactive intestinal peptide in the central nervous system in man. , 1979, American journal of surgery.
[11] J. Fahrenkrug,et al. Vasoactive intestinal polypeptide (VIP) in human cerebrospinal fluid , 1977, Brain Research.
[12] J. Polak,et al. VIP MEASUREMENT IN DISTINGUISHING VERNER‐MORRISON SYNDROME AND PSEUDO VERNER‐MORRISON SYNDROME , 1976, Clinical endocrinology.
[13] A. Bøyum,et al. Isolation of mononuclear cells and granulocytes from human blood. , 1968 .